Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
CaM Kinase
More Information »Calmodulin-dependent kinases (CaMK) are a family of serine/threonine kinases that mediate many of the second messenger effects of Ca2+. At basal Ca2+ levels, CaMKs are maintained in a dormant state through autoinhibition, which can be relieved by increases in Ca2+ levels.
Calmodulin-Dependent Kinase Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 4483 | A 484954 |
| CaM kinase III (eEF-2 kinase) inhibitor | |
| 2457 | Arcyriaflavin A |
| Potent CaM Kinase II and cdk4/cyclin D1 inhibitor. Antiviral agent (anti-HCMV) | |
| 1688 | Autocamtide-2-related inhibitory peptide |
| Selective CaM kinase II inhibitor | |
| 1277 | KN-62 |
| CaM kinase II inhibitor | |
| 1278 | KN-93 |
| CaM kinase II inhibitor. Also K+ channel blocker (KV) | |
| 3439 | NH 125 |
| CaM kinase III (eEF-2 kinase) inhibitor | |
| 1551 | STO-609 acetate |
| Selective CaM kinase kinase inhibitor | |





